Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. Juni 2026 07:00 ET | Quelle: Calroy Health Sciences

Clinical Data Showed Average 67% Pain Score Reduction and 50% Gain in Walking Distance with Cartigenix HP® in 90 Days*†

Calroy Health Sciences' Cartigenix HP® RCT shows 64% WOMAC pain score reduction, 50% walking distance gain, cartilage regeneration biomarkers in 90 days.
22. Mai 2026 07:00 ET | Quelle: Calroy Health Sciences

Cartigenix HP® Backed by Three Human Studies as Clinicians Seek Evidence-Based Joint Health Options

Cartigenix HP® from Calroy: three human studies show measurable cartilage regeneration biomarkers in a placebo-controlled joint health trial.
09. April 2026 10:00 ET | Quelle: Calroy Health Sciences

The Science Behind Glycocalyx Support: Why Rhamnan Sulfate Is Different

Calroy publishes new research explaining how marine-derived rhamnan sulfate may support the endothelial glycocalyx and vascular circulation.
19. März 2026 12:00 ET | Quelle: Calroy Health Sciences

The Endothelial Glycocalyx Explained: How It Helps Regulate Vascular Function

Calroy releases new research explaining the role of the endothelial glycocalyx in circulation and why standard cardiovascular tests miss microvascular func
13. März 2026 12:00 ET | Quelle: Calroy Health Sciences

How Scientists Measure the Circulation You Actually Feel — Not Just the Arteries They Can See

Calroy releases new research explaining how microcirculation and the endothelial glycocalyx influence blood flow, oxygen delivery, and whole-body vitality.